^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    TQB2103

    i
    Other names: TQB2103, TQB-2103, TQB 2103
    Associations

    News

    Trials
    Company:
    Sino Biopharm
    Drug class:
    Topoisomerase I inhibitor, CLDN18.2-targeted antibody-drug conjugate
    Related drugs:
    Associations

    News

    Trials
    over1year
    Clinical Trial Evaluating the Safety of the TQB2103 for Injection (clinicaltrials.gov)
    P1, N=71, Not yet recruiting, Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
    New P1 trial • Metastases
    |
    TQB2103